Summary & Overview
HCPCS Level II J0401: Aripiprazole (Abilify Maintena) Injection, 1 mg
HCPCS Level II code J0401 denotes the 1 mg injectable unit of aripiprazole (Abilify Maintena), a long-acting antipsychotic used for maintenance treatment of schizophrenia and related disorders. This code matters nationally because it standardizes reporting for a high-cost, specialty injectable medication that impacts outpatient behavioral health service delivery, pharmacy benefit management, and utilization review.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of billing and clinical context for the product, common places of service where the drug is administered, and the types of benchmarks and policy topics typically associated with specialty injectable antipsychotics—such as coverage policy considerations, site-of-service implications, and claims-processing nuances. Data not available in the input will be noted where applicable.
The publication provides: (1) a clear description of what the code represents and typical clinical settings; (2) an outline of payer coverage scope and common payer-related considerations; and (3) guidance on where readers can expect to find related reimbursement benchmarks, policy updates, and clinical context in the full publication.
Billing Code Overview
HCPCS Level II code J0401 represents an injection formulation of aripiprazole (Abilify Maintena) dosed at 1 mg per billing unit. The code is used to report the specific pharmacologic product administered for antipsychotic maintenance therapy.
Service type: Medication administration for a long-acting injectable antipsychotic formulation.
Typical site of service: Outpatient clinic, psychiatric clinic, behavioral health center, or other ambulatory infusion/administration settings where long-acting injectable antipsychotic medications are administered.
Clinical & Coding Specifications
Clinical Context
A 28-year-old patient with schizophrenia stabilized on oral aripiprazole presents to an outpatient behavioral health clinic for a scheduled maintenance intramuscular injection of aripiprazole long-acting injectable (Abilify Maintena). The procedure is administered by a licensed nurse under the supervision of a psychiatrist during a follow-up visit. Pre-administration steps include verification of the medication and dose, review of recent symptoms and side effects, assessment for extrapyramidal symptoms and metabolic monitoring, and confirmation of informed consent. The nurse performs site selection (typically deltoid or gluteal), aseptic skin preparation, reconstitution if needed, and intramuscular injection technique, documents lot number and expiration, and observes the patient for 15–30 minutes for immediate adverse reactions. Scheduling typically recurs monthly per product labeling.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Anesthesia modifier: specialty or service reduced? (Note: rare for J-codes) | Not typically used for a medication injection; included only if payer requires clinician identification of primary service. |
22 | Increased procedural services |